Abstract:ObjectaveTo investigate the expression and significance of cyclooxygenase 2 (COX-2) and survivin in breast carcinoma,precancerous lesions and usual duct hyperplasia lesions(UDH).MethodsImmunhistochemical UltraSensitive TM S-P method was applied to detect the expression of COX-2 and survivin in two hundred and seventy-four cases of patients with breast lesions including one hundred and twentyeight cases with invasive ductal carcinomas(IDC),eighty-nine cases with ductal carcinoma in situ(DCIS),and fifty-seven cases with atypical ductal hyperplasia(ADH).Sixty cases with UDH were selected as a control group.The multiple biological parameters including the tumor size,grade,stage were compared with the associations of COX-2 and survivin expressions in breast carcinoma.ResultsCOX-2 was mainly distributed in cytoplasm in IDC,DCIS,ADH and UDH.survivin was mainly distributed in cytoplasm in UDH,but survivin was also distributed in nucleus and cytoplasm in IDC,DCIS and ADH mammary tissues.The positive rates of COX-2 and survivin were 79.5% and 67.2% in IDC,55.1% and 59.6 % in DCIS,and 42.1% and 57.9% in ADH,which were higher than those in UDH tissues(16.7%,1.7%).Compared with UDH,the difference was statistically significant(P<0.05).There were significant differences in the positive expression rates of COX-2 between IDC and DCIS tissues (χ2=14.768,P<0.05),IDC and ADH (χ2=25.293,P<0.05).However,there were no significant differences of survivin expression between IDC(79.5%,67.2%) and DCIS(55.1%,59.6%) tissues(χ2=1.330,P>0.05),IDC(79.5%,67.2%) and ADH(42.1%,57.9%)(χ2=1.484,P>0.05).Positive rates of COX-2 and survivin were found insignificant between ADH and DCIS tissues (χ2=2.331,P>0.05;χ2=0.039,P>0.05,respectively).There was positive correlation in over-expression of COX-2 and survivin with histological grade,lymph node metastasis,distant metastasis and stage of IDC tumor.And the expression of the two proteins were not related with age and tumor size (P>0.05).The expression of COX-2 was correlated positively with survivin(r=0.210,χ2=5.626,P<0.05).Conclusionssurvivin location changes from cell plasma to cell nucleus might participate in oncogenesis and development of breast cancer.The over-expression of COX-2 and survivin might be important biological markers for invasion and metastasis of IDC.The combined detaction of COX-2 and survivin might be the predictors for prognosis and targeting treatment of breat carcinoma.
[1]Aggarwal A,AlRohil RN,Batra A,et al.Expression of integrin α3β1 and cyclooxygenase-2 (COX-2) are positively correlated in human breast cancer[J].BMC Cancer,2014,14:459.
[2]NievesAlicea R,Colburn NH,Simeone AM,et al.Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue Inhibitor of metalloproteinases-2 expression[J].Breast Cancer Res Treat,2009,114(2):203-209.
[3]Kelly RJ,Lopez-Chavez A,Citrin D,et al.Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin[J].Mol Cancer,2011,10(1):35.
[4]张永刚,张作峰,许京中,等.缺氧诱导因子1、血管内皮生长因子和环氧化酶2在乳腺癌中表达的意义[J/CD].中华诊断学电子杂志,2014,2(2):122-126.
[5]Lakhani SR,Ellis IO,Schnitt SJ,et al,eds.WHO classification of tumours of the breast.Lyon,France:IARC Press,2012.
[6]American Joint Committee on Cancer (AJCC).Cancer Stanging Manual,7th ed.New York:Springer,2009.
[7]权继传,解亦斌,田艳涛.国际抗癌联盟胃癌TNM分期系统第七版解读[J/CD].中华诊断学电子杂志,2014,2(1):72-74.
[8]Wang G,Zhang H,Zhang Z,et al.Clinical and pathological characteristics of intraductal proliferative lesions and coexist with invasive ductal carcinomas.Chinese-German J Clin Oncol,2013,12(12):574-580.
[9]Wang G, Qin Y, Zhang J, et al.Nipple Discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer[J]. Int J Mol Sci,2014; 15(6):9546-9565.
[10]徐亮,熊秋云.survivin在乳腺癌中作用的研究进展[J/CD].中华乳腺病杂志(电子版),2012, 6(4):429-435
[11]赵云,李媛媛,张宝刚,等. 小RNA干扰降低COX-2表达对乳腺癌细胞趋化和侵袭能力的影响[J].肿瘤防治研究,2011,38(7):745-748.
[12]王喜梅,湛丽,吴勇军,等.子宫颈癌中C0X-2与p27kipl、MMP-2蛋白表达的关系[J].临床与实验病理学杂志,2005,20(3):303-307.
[13]翟俊山,李楠,王卉,等.环氧化酶2在胃癌组织中的表达及与患者预后的关系[J].中华消化内镜杂志,2007, 24(5):379-381.
[14]曹飞麟,朱敏,谢伯剑,等.COX-2及VEGF在乳腺癌中的表达及其意义[J].中国肿瘤,2007,16(10):825-827.
[15]Adamkov M,Halasova E,Kajo K,et al.survivin:a promising biomarker in breast carcinoma[J].Neoplasma,2010,57(6):572-577.
[16]Jha K,Shukla M,Pandey M.survivin expression and targeting in breast cancer[J].Surg Oncol,2012,21 (2):125-131.
[17]Zohny SF,ElShinawi M.Significance of survivin and Bcl-2 homologous antagonist/killer mRNA in detection of bone metastasis in patients with breast cancer[J].Med Oncol,2011, 28(Suppl1):S108-S114.
[18]Mehar A,MacanasPirard P,Mizokami A,et al.The effects of cyclooxygenase-2 expression in prostate cancer cells:modulation of reaponse to cytotoxic agents[J].J Pharmacol Exp Ther,2008,324(3): 1181-1187.